pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 17·1 min read
save

Trump administration moves special-education oversight to Health and Human Services

Jun 17, 2026·read at STAT ↗RegulatoryNeutral

The Trump administration announced that responsibility for special education will be transferred from the Department of Education to the Department of Health and Human Services. This change is part of the administration's broader effort to restructure education oversight.

Preliminary CDC data show that U.S. infant mortality continued to decline, reaching just under 5.4 deaths per 1,000 live births in 2025, down from 5.6 in 2022 and 2023 and 5.5 in 2024. Experts say the trend represents a statistically meaningful improvement.

In related health news, over-the-counter naloxone options are becoming more widely available, reflecting ongoing efforts to expand access to opioid overdose reversal treatments.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Trump administration will bring special ed to HHS”

read at STAT ↗
825 words · retrieved Jun 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
HERITAGEPATH
drugs
naloxone6REZENOPY2KloxxadoNALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEnaloxone hydrochloride
topics
Oncology3Psychiatry & CNS2ApprovalInfectious DiseaseVaccines

related stories

  • Jun 16FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdosefda press
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 12h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Aug 6FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanomafda press
  • Aug 5Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuringFierce Biotech